ConductScience.org, home

Paper19320232

Simplification strategies to reduce antiretroviral drug exposure: progress and prospects.

McKinnon JE and 2 others. Antivir Ther, 2009. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Simplification strategies to reduce antiretroviral drug exposure: progress and prospects. Papers, record 19320232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19320232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Simplification strategies to reduce antiretroviral drug exposure: progress and prospects.
PubMed
Journal
Antivir Ther
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
0.75
iCite
Revised in PubMed
2025-05-29
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McKinnon JEJohn E
2Mellors JWJohn W
3Swindells SSusan

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-HIV AgentsMajor topic
HIV InfectionsMajor topic
HIV Protease InhibitorsMajor topic
HIV-1Major topic
Reverse Transcriptase InhibitorsMajor topic
Administration, Oral
Antiretroviral Therapy, Highly Active
Drug Administration Schedule
Drug Combinations
Drug Resistance, Multiple, Viral
Drug Therapy, Combination
Forecasting
Humans
Medication Adherence
Randomized Controlled Trials as Topic
Ritonavir

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
KL2 TR000146NCATS NIH HHSUnited StatesKL2TR000146PubMed and NIHNIH RePORTER
T32 AI007333NIAID NIH HHSUnited StatesT32AI007333PubMed and NIHNIH RePORTER

Download CSV of grants

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116267763Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects.J Infect Dis2005https://conductscience.org/library/papers/16267763PubMed
212001042A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection.J Infect Dis2002https://conductscience.org/library/papers/12001042PubMed
315798380Early virologic failure in a pilot study evaluating the efficacy of therapy containing once-daily abacavir, lamivudine, and tenofovir DF in treatment-naive HIV-infected patients.AIDS Patient Care STDS2005https://conductscience.org/library/papers/15798380PubMed
417617270Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.Lancet2007https://conductscience.org/library/papers/17617270PubMed
510601505Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.N Engl J Med1999https://conductscience.org/library/papers/10601505PubMed
614668455Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection.N Engl J Med2003https://conductscience.org/library/papers/14668455PubMed
712153332Clinical implications of CNS penetration of antiretroviral drugs.CNS Drugs2002https://conductscience.org/library/papers/12153332PubMed
817117019The level of persistent HIV viremia does not increase after successful simplification of maintenance therapy to lopinavir/ritonavir alone.AIDS2006https://conductscience.org/library/papers/17117019PubMed
917001298A once-daily combination tablet (Atripla) for HIV.Med Lett Drugs Ther2006https://conductscience.org/library/papers/17001298PubMed
109683207Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study.Lancet1998https://conductscience.org/library/papers/9683207PubMed
1111734634Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11734634PubMed
1217461744Monotherapy with lopinavir/ritonavir.Expert Opin Investig Drugs2007https://conductscience.org/library/papers/17461744PubMed
1317434845Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study.HIV Clin Trials2007https://conductscience.org/library/papers/17434845PubMed
1412514410
Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects.
J Acquir Immune Defic Syndr2003https://conductscience.org/library/papers/12514410PubMed
1517159658Early virologic rebound in a pilot trial of ritonavir-boosted atazanavir as maintenance monotherapy.J Acquir Immune Defic Syndr2007https://conductscience.org/library/papers/17159658PubMed
1616807250Benefits and concerns of simplification strategies in HIV-infected patients.J Antimicrob Chemother2006https://conductscience.org/library/papers/16807250PubMed
1716452065Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adults.HIV Clin Trials2005https://conductscience.org/library/papers/16452065PubMed
1811596076Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.J Med Virol2001https://conductscience.org/library/papers/11596076PubMed
1911192858The ADAM study continued: maintenance therapy after 50 weeks of induction therapy.AIDS2001https://conductscience.org/library/papers/11192858PubMed
2018097218Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.AIDS2008https://conductscience.org/library/papers/18097218PubMed

See all 55 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
41601776Pharmacoeconomic perspectives on HIV: integrating data for long-term treatment and prevention.Front Med (Lausanne)2025https://conductscience.org/library/papers/41601776PubMed
41498461
Effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV: Data from the COMBINE-2 study.
HIV Med2026https://conductscience.org/library/papers/41498461PubMed
31802641Two-drug antiretroviral regimens: an assessment of virologic response and durability among treatment-experienced persons living with HIV in the OPERA® Observational Database.J Int AIDS Soc2019https://conductscience.org/library/papers/31802641PubMed
25924841HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.Retrovirology2015https://conductscience.org/library/papers/25924841PubMed
24802242Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).PLoS One2014https://conductscience.org/library/papers/24802242PubMed
24777106Enhanced antiretroviral therapy in rhesus macaques improves RT-SHIV viral decay kinetics.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24777106PubMed
22646049Unboosted atazanavir for treatment of HIV infection: rationale and recommendations for use.Drugs2012https://conductscience.org/library/papers/22646049PubMed
21931626Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort.PLoS One2011https://conductscience.org/library/papers/21931626PubMed
21910865Kinetics of the viral cycle influence pharmacodynamics of antiretroviral therapy.Biol Direct2011https://conductscience.org/library/papers/21910865PubMed
21886816Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen.PLoS One2011https://conductscience.org/library/papers/21886816PubMed
21845035Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs.Patient Prefer Adherence2011https://conductscience.org/library/papers/21845035PubMed
21817194Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapy.Antivir Ther2011https://conductscience.org/library/papers/21817194PubMed
20701796
Evaluation of HIV protease and nucleoside reverse transcriptase inhibitors on proliferation, necrosis, apoptosis in intestinal epithelial cells and electrolyte and water transport and epithelial barrier function in mice.
BMC Gastroenterol2010https://conductscience.org/library/papers/20701796PubMed
20213370Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff.Wien Klin Wochenschr2010https://conductscience.org/library/papers/20213370PubMed
19958227NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.Nanomedicine (Lond)2009https://conductscience.org/library/papers/19958227PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
MLC123209PubTator's text mininghttps://conductscience.org/library/genes/23209NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19320232

GET https://conductscience.org/api/papers/v1/19320232/references?page=2